decitabine
Showing 1 - 25 of 220
AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)
Recruiting
- AML
- MDS
- Decitabine
- Venetoclax
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital
Nov 30, 2023
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
- Venetoclax
- Decitabine
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)
Not yet recruiting
- Poor Graft Function
- Decitabine
- +3 more
- (no location specified)
Jun 8, 2023
Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)
Not yet recruiting
- Ovarian Cancer
- Decitabine
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Aug 1, 2023
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
Healthy Trial in San Antonio (Decitabine, Tetrahydrouridine)
Recruiting
- Healthy
- Decitabine
- Tetrahydrouridine
-
San Antonio, TexasWorldwide Clinical Trails Early Phase Services
Apr 14, 2023
Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Venetoclax
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Mar 22, 2023
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)
Not yet recruiting
- Poor Graft Function
- decitabine
- +4 more
- (no location specified)
Dec 29, 2022
Refractory Aplastic Anemia Trial in Tianjin (Decitabine)
Terminated
- Refractory Aplastic Anemia
- Decitabine
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Aug 25, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
- Decitabine
- Filgrastim
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)
Recruiting
- Recurrent Leukemia
- Refractory Leukemia
- Decitabine
- Tegavivint
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- STAT Inhibitor OPB-111077
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Decitabine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,
Completed
- Acute Myeloid Leukemia
- +2 more
- Decitabine
- +2 more
-
Minneapolis, Minnesota
- +2 more
Nov 2, 2022
MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)
Recruiting
- Myelodysplastic Syndromes
- MDS/MPN Crossover Syndromes
- 5-azacytidine
- Decitabine
-
Cleveland, OhioCleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022
Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,
Completed
- Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
- +4 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Acute Myelogenous Leukemia Trial in Rochester (Decitabine)
Completed
- Acute Myelogenous Leukemia
- Decitabine
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)
Recruiting
- Leukemia
- Cladribine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 23, 2022
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022